Wolfgang Schoenfeld
Presidente presso EUCODIS Bioscience GmbH Deutschland
Posizioni attive di Wolfgang Schoenfeld
Società | Posizione | Inizio | Fine |
---|---|---|---|
EUCODIS Bioscience GmbH Deutschland
EUCODIS Bioscience GmbH Deutschland Miscellaneous Commercial ServicesCommercial Services EUCODIS GmbH researches and develops products for life science applications. It develops products for life science applications by utilizing vivo recombination and somatic hypermutation technology. The company focuses on development of products such as industrial enzymes, therapeutic proteins, agrochemicals, seed technologies, transgenic animals, biosynthetic pathways and human antibodies. The company was founded in 2004 and is headquartered in Vienna, Austria. | Presidente | 01/01/2004 | - |
Storia della carriera di Wolfgang Schoenfeld
Precedenti posizioni note di Wolfgang Schoenfeld
Società | Posizione | Inizio | Fine |
---|---|---|---|
Ruhr-Universität Bochum | Corporate Officer/Principal | - | - |
BAYER AG | Corporate Officer/Principal | 01/01/1991 | - |
Mixis Genetics Ltd
Mixis Genetics Ltd Pharmaceuticals: OtherHealth Technology Part of Teva Pharmaceutical Industries Ltd., Mixis Genetics Ltd is a French company that develops medicinal chemicals and botanical products. The company is based in Paris, France. The CEO of the company is Gilles Amsallem. Mixis Genetics was acquired by PLIVA dd, part of Teva Pharmaceutical Industries Ltd. from October 24, 2006 on April 01, 1999 for $3.26 million. | Corporate Officer/Principal | - | - |
PLIVA dd
PLIVA dd Pharmaceuticals: MajorHealth Technology PLIVA d.d. is a joint stock company incorporated and domiciled in the Republic of Croatia. The registered office is at Vukovarska 49, Zagreb. The Company is the parent of the PLIVA Group (“the Group”). The Group manufactures and supplies a wide range of pharmaceutical products as its core business. Non-core businesses consist of the manufacture and supply of DDDI products (diagnostics, disinfectants, dialysis, and infusions). | Corporate Officer/Principal | - | - |
EUCODIS Bioscience GmbH
EUCODIS Bioscience GmbH Drugstore ChainsRetail Trade EUCODIS Bioscience GmbH provides enzyme solutions. Its applications are used in biopharma, chemicals and cosmetics industries. The company is headquartered in Vienna, Austria. | Fondatore | 01/01/2004 | - |
Presidente | 01/01/2007 | - |
Formazione di Wolfgang Schoenfeld
RWTH Aachen University | Doctorate Degree |
Statistiche
Distribuzione geografica
Germania | 5 |
Austria | 2 |
Francia | 2 |
Posizioni
Corporate Officer/Principal | 4 |
President | 2 |
Doctorate Degree | 1 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
BAYER AG | Health Technology |
Aziende private | 4 |
---|---|
EUCODIS Bioscience GmbH Deutschland
EUCODIS Bioscience GmbH Deutschland Miscellaneous Commercial ServicesCommercial Services EUCODIS GmbH researches and develops products for life science applications. It develops products for life science applications by utilizing vivo recombination and somatic hypermutation technology. The company focuses on development of products such as industrial enzymes, therapeutic proteins, agrochemicals, seed technologies, transgenic animals, biosynthetic pathways and human antibodies. The company was founded in 2004 and is headquartered in Vienna, Austria. | Commercial Services |
EUCODIS Bioscience GmbH
EUCODIS Bioscience GmbH Drugstore ChainsRetail Trade EUCODIS Bioscience GmbH provides enzyme solutions. Its applications are used in biopharma, chemicals and cosmetics industries. The company is headquartered in Vienna, Austria. | Retail Trade |
Mixis Genetics Ltd
Mixis Genetics Ltd Pharmaceuticals: OtherHealth Technology Part of Teva Pharmaceutical Industries Ltd., Mixis Genetics Ltd is a French company that develops medicinal chemicals and botanical products. The company is based in Paris, France. The CEO of the company is Gilles Amsallem. Mixis Genetics was acquired by PLIVA dd, part of Teva Pharmaceutical Industries Ltd. from October 24, 2006 on April 01, 1999 for $3.26 million. | Health Technology |
PLIVA dd
PLIVA dd Pharmaceuticals: MajorHealth Technology PLIVA d.d. is a joint stock company incorporated and domiciled in the Republic of Croatia. The registered office is at Vukovarska 49, Zagreb. The Company is the parent of the PLIVA Group (“the Group”). The Group manufactures and supplies a wide range of pharmaceutical products as its core business. Non-core businesses consist of the manufacture and supply of DDDI products (diagnostics, disinfectants, dialysis, and infusions). | Health Technology |
- Borsa valori
- Insiders
- Wolfgang Schoenfeld
- Esperienza